ChemFeeds Site Navigation:
Journal Selection:
Search:

1) Correction: Axl Kinase as a Key Target for Oncology: Focus on Small Molecule Inhibitors (Molecular Cancer Therapeutics) Thursday June 4th 2015


2) Correction: Paclitaxel-Loaded PEG-PE-Based Micellar Nanopreparations Targeted with Tumor-Specific Landscape Phage Fusion Protein Enhance Apoptosis and Efficiently Reduce Tumors (Molecular Cancer Therapeutics) Thursday June 4th 2015


3) Nitazoxanide for Drug Repositioning against Colon Cancer (Molecular Cancer Therapeutics) Thursday June 4th 2015


4) GAB2 Expression in Ovarian Cancer (Molecular Cancer Therapeutics) Thursday June 4th 2015


5) Genomic Biomarker Actionability in 439 Patients with Cancer (Molecular Cancer Therapeutics) Thursday June 4th 2015


6) FBXW7 and CRY2 in Chemoresistance of Colorectal Cancer (Molecular Cancer Therapeutics) Thursday June 4th 2015


7) PTEN Predicts Response of Uterine Cancer to FAK Inhibitor (Molecular Cancer Therapeutics) Thursday June 4th 2015


8) MAP17 Determines Sensitivity to Bortezomib (Molecular Cancer Therapeutics) Thursday June 4th 2015


9) TR4 Promotes Metastasis in Prostate Cancer Stem Cells (Molecular Cancer Therapeutics) Thursday June 4th 2015


10) Targeting MASTL and FOXM1 for Radiosensitization (Molecular Cancer Therapeutics) Thursday June 4th 2015


11) Radiosensitization by Arabinoside-Nucleoside Analogues (Molecular Cancer Therapeutics) Thursday June 4th 2015


12) miR-125-HER2 Pathway as a Target in Small Cell Lung Cancer (Molecular Cancer Therapeutics) Thursday June 4th 2015


13) Targeting Survivin in RCC (Molecular Cancer Therapeutics) Thursday June 4th 2015


14) Notch1-Mediated Growth Suppression by Xanthohumol (Molecular Cancer Therapeutics) Thursday June 4th 2015


15) Dual Role for IL1{beta} in Tumors (Molecular Cancer Therapeutics) Thursday June 4th 2015


16) CD30 Expression and Brentuximab Vedotin Resistance (Molecular Cancer Therapeutics) Thursday June 4th 2015


17) Calcitriol in Esophageal Squamous Cell Carcinoma (Molecular Cancer Therapeutics) Thursday June 4th 2015


18) MEK/Aurora Kinase Inhibition in Melanoma (Molecular Cancer Therapeutics) Thursday June 4th 2015


19) CDK4 Inhibition in Imatinib-Resistant Fibrosarcomatous DFSP (Molecular Cancer Therapeutics) Thursday June 4th 2015


20) Synergy of Radiotherapy and HPV Vaccine for HNSCC Treatment (Molecular Cancer Therapeutics) Thursday June 4th 2015


21) Antibody-Mediated Targeting of MHC (Molecular Cancer Therapeutics) Thursday June 4th 2015


22) Delivery of PEGylated Compounds to Cancer Cells (Molecular Cancer Therapeutics) Thursday June 4th 2015


23) Targeting of ER- Breast Cancer with CRT0066101 (Molecular Cancer Therapeutics) Thursday June 4th 2015


24) CC-223, a Potent and Selective Inhibitor of mTOR Kinase (Molecular Cancer Therapeutics) Thursday June 4th 2015


25) Anti-MYC Prodrug Nanotherapy for Myeloma (Molecular Cancer Therapeutics) Thursday June 4th 2015


26) Myb Inhibitor (Molecular Cancer Therapeutics) Thursday June 4th 2015


27) Myb-p300 Interaction (Molecular Cancer Therapeutics) Thursday June 4th 2015


28) Suppression of Breast and Colon Cancer Models Using RNAi (Molecular Cancer Therapeutics) Wednesday May 6th 2015


29) Oncolytic Activity of rNDV-B1/Fas (Molecular Cancer Therapeutics) Wednesday May 6th 2015


30) MGMT-Mediated Response to Temozolomide and PARP Inhibitors (Molecular Cancer Therapeutics) Wednesday May 6th 2015


31) Frequent TSC2 Loss in HCC and Everolimus Response (Molecular Cancer Therapeutics) Wednesday May 6th 2015


32) Druggable Vulnerabilities in E-Cadherin-Deficient Cells (Molecular Cancer Therapeutics) Wednesday May 6th 2015


33) Loss of NISCH Promotes Proliferation and Invasion (Molecular Cancer Therapeutics) Wednesday May 6th 2015


34) Endostatin Has Novel ATPase Activity (Molecular Cancer Therapeutics) Wednesday May 6th 2015


35) Imatinib and Dasatinib Reduce Myeloid Suppressor Cells (Molecular Cancer Therapeutics) Wednesday May 6th 2015


36) Targeting AKT for Glioblastoma Radiosensitization (Molecular Cancer Therapeutics) Wednesday May 6th 2015


37) HOTAIR and PCBP1 in Gastric Cancer (Molecular Cancer Therapeutics) Wednesday May 6th 2015


38) {beta}III-Tubulin Regulates Brain Metastases (Molecular Cancer Therapeutics) Wednesday May 6th 2015


39) ABT-806: A Tumor-Selective EGFR-Targeting Antibody (Molecular Cancer Therapeutics) Wednesday May 6th 2015


40) Tissue Factor Antibody-Drug Con{#x0237}ugate (Molecular Cancer Therapeutics) Wednesday May 6th 2015


41) Aurora Kinase Inhibition in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Wednesday May 6th 2015


42) Targeting Hsp27 in NSCLC (Molecular Cancer Therapeutics) Wednesday May 6th 2015


43) P7170, a Novel Potent mTORC1/C2 and ALK1 Inhibitor (Molecular Cancer Therapeutics) Wednesday May 6th 2015


44) Targeting Wnts at the Source (Molecular Cancer Therapeutics) Wednesday May 6th 2015


45) Multifunctional Micelles for the Reversal of Drug Resistance (Molecular Cancer Therapeutics) Thursday April 9th 2015


46) (CAG)n and Protein Expression of AR in Colorectal Cancer (Molecular Cancer Therapeutics) Thursday April 9th 2015


47) BLM in Breast Cancer (Molecular Cancer Therapeutics) Thursday April 9th 2015


48) Biomarkers Change in Response to Bevacizumab and Everolimus (Molecular Cancer Therapeutics) Thursday April 9th 2015


49) Targeting JAK/STAT3 Inhibits Ovarian Cancer (Molecular Cancer Therapeutics) Thursday April 9th 2015


50) Integrin-Linked Kinase in RCC (Molecular Cancer Therapeutics) Thursday April 9th 2015


51) Dual PI3K/mTOR Inhibitors Enhance ERK Activation via mTORC2 (Molecular Cancer Therapeutics) Thursday April 9th 2015


52) p53-Dependent G2 Phase Arrest by FTD (Molecular Cancer Therapeutics) Thursday April 9th 2015


53) OATPs and Docetaxel Disposition (Molecular Cancer Therapeutics) Thursday April 9th 2015


54) An IGF-Trap for Cancer Treatment (Molecular Cancer Therapeutics) Thursday April 9th 2015


55) PAPP-A as a Therapeutic Target for Ovarian Cancer (Molecular Cancer Therapeutics) Thursday April 9th 2015


56) Nonclinical Evaluation of the Anti-SEMA4D Antibody VX15/2503 (Molecular Cancer Therapeutics) Thursday April 9th 2015


57) Acquired Resistance to Trastuzumab-ADC (Molecular Cancer Therapeutics) Thursday April 9th 2015


58) C4.4A Is the Functional Receptor of AGR2 (Molecular Cancer Therapeutics) Thursday April 9th 2015


59) Pharmacodynamics and Antitumor Efficacy of XL147 (SAR245408) (Molecular Cancer Therapeutics) Thursday April 9th 2015


60) Carboplatin {+/-} ABT888 in BRCA and Non-BRCA Intracranial TNBC (Molecular Cancer Therapeutics) Thursday April 9th 2015


61) IKK{beta} Regulates VEGF Expression (Molecular Cancer Therapeutics) Thursday April 9th 2015


62) Choline Kinase Inhibition for Treatment of Brain Tumors (Molecular Cancer Therapeutics) Thursday April 9th 2015


63) PARP Inhibitor and 5FU in the Treatment of Acute Leukemias (Molecular Cancer Therapeutics) Thursday April 9th 2015


64) ATF4 Mediates Cellular Response to YW3-56 (Molecular Cancer Therapeutics) Thursday April 9th 2015


65) Functional Genetic WEE1 Sensitivity Screen (Molecular Cancer Therapeutics) Thursday April 9th 2015


66) Preclinical Evaluation of Letrozole for Glioma Treatment (Molecular Cancer Therapeutics) Thursday April 9th 2015


67) PD-L1 IHC as a Predictive Biomarker in Cancer Immunotherapy (Molecular Cancer Therapeutics) Thursday April 9th 2015


68) Correction: MEDI-573, Alone or in Combination with Mammalian Target of Rapamycin Inhibitors, Targets the Insulin-like Growth Factor Pathway in Sarcomas (Molecular Cancer Therapeutics) Thursday March 12th 2015


69) CTC Detection by Microfiltration and Adenoviral Imaging (Molecular Cancer Therapeutics) Thursday March 12th 2015


70) CTA Expression in HNSCC (Molecular Cancer Therapeutics) Thursday March 12th 2015


71) Improved CTC Detection Using EpCAM and MCAM in Breast Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


72) Synergistic EGFR and HER2 Blockade Enhances Radiation Effect (Molecular Cancer Therapeutics) Thursday March 12th 2015


73) Pdcd4 Enhances the Efficacy of OSI-906 in CRC (Molecular Cancer Therapeutics) Thursday March 12th 2015


74) Redox Modulation for Overcoming Gemcitabine Resistance (Molecular Cancer Therapeutics) Thursday March 12th 2015


75) Notch Activity Identifies Breast Cancer Stem Cells (Molecular Cancer Therapeutics) Thursday March 12th 2015


76) Targeting Androgen Receptor in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


77) Vemurafenib Resistance Signature in Melanoma (Molecular Cancer Therapeutics) Thursday March 12th 2015


78) Murine Ascites Enriches for Ovarian CSCs Expressing memGRP78 (Molecular Cancer Therapeutics) Thursday March 12th 2015


79) CD30 Expression in Mesothelioma (Molecular Cancer Therapeutics) Thursday March 12th 2015


80) HDAC6 Regulates Hh Signaling (Molecular Cancer Therapeutics) Thursday March 12th 2015


81) Stat5a/b Inhibition Potentiates Antiandrogen Therapy in Prostate Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


82) Oncogenic Mechanisms and Prevalence of FGFR3-BAIAP2L1 (Molecular Cancer Therapeutics) Thursday March 12th 2015


83) SYD985 Is Effective in Low HER2-Expressing Breast Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


84) Tumor Evasion of Antibody Immunity (Molecular Cancer Therapeutics) Thursday March 12th 2015


85) Superior HER2 Targeting by Antibody Mixtures (Molecular Cancer Therapeutics) Thursday March 12th 2015


86) Protease-Activated Peptides (Molecular Cancer Therapeutics) Thursday March 12th 2015


87) AMG 232 Regresses Tumors and Enhances Chemotherapy Efficacy (Molecular Cancer Therapeutics) Thursday March 12th 2015


88) Hsp70-Bag3 as a Protein-Protein Interaction Target (Molecular Cancer Therapeutics) Thursday March 12th 2015


89) Hedgehog Pathway Inhibitors and Basal Cell Carcinoma (Molecular Cancer Therapeutics) Thursday March 12th 2015


90) Predictive Biomarkers for IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


91) Targeting Wee-1 Kinase in mutp53 HNSCC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


92) BRG1 Bromodomain Radiosensitizes Tumor Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


93) Metformin Inhibits Rac1 GTPase and Cancer Cell Migration (Molecular Cancer Therapeutics) Tuesday February 10th 2015


94) Role of TDP1 and TOP1 in Colorectal Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


95) GSK3{beta} Sustains Glioblastoma Invasion (Molecular Cancer Therapeutics) Tuesday February 10th 2015


96) CD147 Promotes Radioresistance in HCC Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


97) Sequential Anti-EGFR Therapy in Lung Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


98) Onartuzumab and Erlotinib Inhibits EGFR-Mutated NSCLC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()